Repros Therapeutics Inc Share Price

Stocks

27/18/27	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/17/16	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/17/13	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
12/17/12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/17/12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/15/02	Apple : Les valeurs à suivre sur les marchés américains
02/15/02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.07%	-3.49%	-3.35%	+10.44%	4.69TCr
REVOLUTION MEDICINES, INC.	+0.25%	+1.65%	+399.22%	+634.87%	4.02TCr
BEONE MEDICINES AG	-0.27%	+4.45%	+11.81%	+65.64%	3.62TCr
IQVIA HOLDINGS INC.	+0.35%	+0.87%	+4.46%	-10.16%	3.47TCr
CELLTRION, INC.	+3.14%	+1.02%	+4.76%	+40.92%	2.79TCr
MEDPACE HOLDINGS, INC.	-0.73%	+11.84%	+34.39%	+134.36%	1.68TCr
ASCENDIS PHARMA A/S	+0.47%	-2.74%	-	-	1.67TCr
EUROFINS SCIENTIFIC SE	+0.42%	-5.52%	-3.43%	+9.03%	1.31TCr
ICON PUBLIC LIMITED COMPANY	-2.68%	-2.49%	-11.36%	-33.61%	1.27TCr
Average	+0.20%	+0.83%	+54.56%	+106.44%	2.73TCr
Weighted average by Cap.	+0.48%	+0.91%	+74.42%	+136.27%

Employees

Sector